USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Checkmate Limited

USPTO PatentsView assignee record - 5 granted patents across 6 technology areas, recorded in grant years 2015–2018. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A62B (Devices, Apparatus OR Methods FOR Life-saving).

RSS updates for this company

The verdict

According to USPTO PatentsView, Checkmate ranks #45,607 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 6 technology areas.

#45,607
of 49,997 US assignees by volume
17th percentile
by Innovation Score (25.4/100)
17.6
avg claims per patent
-100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R45607 · Foreign Corporation #45,607 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 5 grants
  • BOTTOM-DECILE #45,607/49,997
  • PHOTO-FINISH Chaperone Therapeutics
  • CPC-NARROW A62B · 6 areas
  • INNOV-THIN 25.4/100
  • CLAIMS-RICH 17.6 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -100% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Chaperone Therapeutics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Checkmate

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Checkmate's Innovation Score is 25.4/100 (17th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Checkmate's grants concentrate

Checkmate Limited is a focused PatentsView assignee: 6 CPC subclasses with 80% of grants classified under A62B (Devices, Apparatus OR Methods FOR Life-saving). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2018. By volume, Checkmate sits between Chaperone Therapeutics, Inc. and Chem Optics Inc.

Who files at Checkmate's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Checkmate holds 5 patents at rank #45,510, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Checkmate

By rank, the assignees closest to #45,510 in granted patent volume.

Leaders in A62B (Devices)

Other assignees with the most granted patents in Checkmate's primary technology class.

Checkmate's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

25 17th percentile higher than 17% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 201520162018 1
USPTO utility patent grants by year · 2015–2018

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Checkmate Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 40.0%
2016 2 40.0%
2018 1 20.0%

Where it ranks

Overall rank by patents

#45,607

of 49,997 tracked assignees

Innovation Score

25.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Checkmate Limited's patent record in context - here's where to go next.

  • Checkmate Limited's lead technology class is A62B (Devices, Apparatus OR Methods FOR Life-saving), 80% of its portfolio - see every assignee active in that class. Explore A62B
  • Ranked #45,607 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Checkmate Limited against Chaperone Therapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 25.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.